Life Sciences & Healthcare 2/9

End-of-year review: CNS & Rare Disease

‘Although it has definitely been a tricky and challenging year for neuroscience – and biopharma in general – there have been some amazing...

The commercial mindset: Rani Therapeutics' Kate McKinley discusses her career

Kate spoke to Joe Knight on the Venari Podcast ‘I’m a huge proponent for working in large, established companies earlier in one’s...

What have we learned from talking to HealthTech CEOs?

Cristian Owen reflects on insights from the first series of his HealthTech CEO podcast One of the best things about my job is that I get...

Mohamed Issa on commercial strategy, entrepreneurship, and Big Pharma leadership

Joe Knight spoke to Janssen's SVP of Immunology In this episode of the Venari Podcast, our Life Sciences Commercial Consultant, Joe...

From Pharma to MedTech with BrightInsight CEO, Kal Patel

Latest guest on the HealthTech CEO podcast series opens up on his career path Founding a company wasn’t in the script for BrightInsight...

'The start of something special' - Floreo CEO Vijay Ravindran on the potential of VR in Healthcare

Vijay appeared on the Venari Podcast’s HealthTech CEO series ‘I’ve had what I think is a fairly unique path,’ says Vijay Ravindran. It’s...

Opera, sports & long COVID – multipurpose HealthTech with Airofit CEO Christian Tullberg

Christian appeared on the Venari Podcast’s HealthTech CEO series As a sports-mad classically trained singer, Christian Tullberg Poulsen...

Data, strategy, and digital transformation: a conversation with Rhea Fox

Tom Woods spoke to Rhea on the Venari Podcast For Rhea Fox, ‘the tool kit is the tool kit, regardless of industry.’ It’s a...

As the first Chief Commercial Officer series draws to a close, what have we learned from the CCOs?

Joe Knight reflects on a successful season of interviews I was keen to create a series for the Venari Podcast – and, given the fantastic...